tiprankstipranks
Trending News
More News >
Immunovant (IMVT)
NASDAQ:IMVT
Advertisement

Immunovant (IMVT) Similar Stocks

Compare
902 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Immunovant
$16.11
$2.88B
-45.59%
11 Buy
2 Hold
0 Sell
Strong Buy
Protagonist Therapeutics
$65.47
$3.99B
91.87
48.93%
12 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$42.50
$3.93B
-17.79%
15 Buy
1 Hold
0 Sell
Strong Buy
Mirum Pharmaceuticals
$73.74
$3.64B
87.82%
12 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$56.92
$4.11B
32.25%
17 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$9.28
$556.24M
-81.38%
9 Buy
7 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IMVT
Immunovant
16.11
-13.91
-46.34%
PTGX
Protagonist Therapeutics
65.47
21.29
48.19%
CRNX
Crinetics Pharmaceuticals
42.50
-8.20
-16.17%
MIRM
Mirum Pharmaceuticals
73.74
35.89
94.82%
KYMR
Kymera Therapeutics
56.92
13.58
31.33%
MLTX
MoonLake Immunotherapeutics
9.28
-38.41
-80.54%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis